Neurocrine Biosciences Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $608.5M | $1.73B | $187.1M |
| FY2021 | $698.5M | $2.07B | $340.8M |
| FY2022 | $660.9M | $2.37B | $262.9M |
| FY2023 | $1.02B | $3.25B | $251.1M |
| FY2024 | $1.13B | $3.72B | $233.0M |